I don't think P was anticipated to be overly succe
Post# of 72440
Posted On: 05/26/2016 1:56:18 PM
I don't think P was anticipated to be overly successful. Actually, I would take P over the other products on the market from the results we've seen. I thought the P test was very successful. Remember, they started at 50 mg. 200 mg results were outstanding.
The Judge dismissing the case is one of the biggest items on my radar for a long time. It's what got us here and can remove that.
B-ASSSI 3, what's taking so long? Grant funding, lab availability my guess.
B-OM, interim results needed.
The results for Kevetrin have taken a long time but think this is normal plus the researchers extended the interest in using it now, unapproved, and don't really know if they have stopped using it. That's a pretty strong positive. BK said medical journal articles can take up to 2 years. Who really knows.
The neighborhood article, yards are already planted, blooming so why have it now. One has to take the photos at prime time for the article then it has to be written. Do it in spring to have the best viewership.
The consistent selling can very well be Aspire if they are getting .50 profit on the every dollar. That goes into the bank for research. Add the shorts who will play this until there is motivation to cover and go long.
The economy is sucking here and around the world. Today, watching Bloomberg Surveillance, they were talking about hedge funds crashing and people taking their money out and it's industry wide. Our guy at Morgan Stanley is their top guy in the country and he's sucking rocks right now.
But the economy will come back, stock will move higher, CTIX will continue to test product through to FDA approval and it could easily be P as one of their first. Don't see any failures yet with any product.
I'm sure Leo isn't in his swim suit but is playing in an ocean of sharks.
Today's PR follow-up was in response to those who 'didn't get it' with their initial report which was probably hurried due to the long week-end that started today for many. Today's information at the time of the initial report would have been better.
We have to remember that the overwhelming majority of people do not read chat rooms to make decisions on what stock to purchase. Manipulators are more suited for that arena. Not suggesting you or me of course but track records are the best way to make stock decisions and most people go for the established winners for expected outcomes.
Leo is building a good if not great company and I have the time to let him do it and will do so. I wouldn't be surprised if we don't have a partnership for P within a reasonable time, sooner than you think. The p3 study will have to be approved, locations selected and trial run. The trial is very fast. He could have that partner sooner than we think. Less money now or much more later. The companies with mega dollars might want to risk theirs now vs waiting until it's much more expensive. jmo
The Judge dismissing the case is one of the biggest items on my radar for a long time. It's what got us here and can remove that.
B-ASSSI 3, what's taking so long? Grant funding, lab availability my guess.
B-OM, interim results needed.
The results for Kevetrin have taken a long time but think this is normal plus the researchers extended the interest in using it now, unapproved, and don't really know if they have stopped using it. That's a pretty strong positive. BK said medical journal articles can take up to 2 years. Who really knows.
The neighborhood article, yards are already planted, blooming so why have it now. One has to take the photos at prime time for the article then it has to be written. Do it in spring to have the best viewership.
The consistent selling can very well be Aspire if they are getting .50 profit on the every dollar. That goes into the bank for research. Add the shorts who will play this until there is motivation to cover and go long.
The economy is sucking here and around the world. Today, watching Bloomberg Surveillance, they were talking about hedge funds crashing and people taking their money out and it's industry wide. Our guy at Morgan Stanley is their top guy in the country and he's sucking rocks right now.
But the economy will come back, stock will move higher, CTIX will continue to test product through to FDA approval and it could easily be P as one of their first. Don't see any failures yet with any product.
I'm sure Leo isn't in his swim suit but is playing in an ocean of sharks.
Today's PR follow-up was in response to those who 'didn't get it' with their initial report which was probably hurried due to the long week-end that started today for many. Today's information at the time of the initial report would have been better.
We have to remember that the overwhelming majority of people do not read chat rooms to make decisions on what stock to purchase. Manipulators are more suited for that arena. Not suggesting you or me of course but track records are the best way to make stock decisions and most people go for the established winners for expected outcomes.
Leo is building a good if not great company and I have the time to let him do it and will do so. I wouldn't be surprised if we don't have a partnership for P within a reasonable time, sooner than you think. The p3 study will have to be approved, locations selected and trial run. The trial is very fast. He could have that partner sooner than we think. Less money now or much more later. The companies with mega dollars might want to risk theirs now vs waiting until it's much more expensive. jmo
(6)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼